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un@yahAbstract Introduction: In the case of an undifferentiated nasopharyngeal carcinoma coexistingwith
asymptomatic Paget’s disease it may be difﬁcult to determine the stage. A case of a clinically localized
nasopharyngeal carcinoma coexisting with incidental Paget’s disease is reported herein.
Case report: A 51-year-old woman was admitted who presented a permanent left nasal obstruction,
combined with ipsilateral epistaxis. She was diagnosed as having a nasopharyngeal carcinoma. The
bone scan showed widespread homogenous increased remodelling throughout the skeleton. Radio-
graphs showed an increase in bone density and cortical thickening. Magnetic resonance imaging
(MRI) of the right leg excluded bone metastases. We concluded that this was a localized nasopharyn-
geal carcinoma associated with asymptomatic Paget’s disease of the bone. The patient showed a good
response to concomitant radio chemotherapy.
Discussion: In imaging, the skeletal lesions of both nasopharyngeal cancer and Paget’s disease may
closely resemble each other. No biological markers of bone resorption or formation can differentiateEar, Nose, Throat and Allied
evier B.V. All rights reserved.
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Figure 1 (A) Anterior technicium-9
the right femur, the ipsilateral iliac b
sterno-clavicular line and the right cl
126 B. Hammami et al.between the two entities. We used three radiological explorations to make the diagnosis. However we
believe, after reviewing the literature, that ﬂuorodeoxyglucose positron emission tomography (FDG
PET) can be helpful in this situation.
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Production and hosting by Elsevier B.V. All rights reserved.Figure 2 Anterioposterior radiograph of the pelvis shows diffuse
sclerosis in the right iliac bone with trabecular and cortical
thickening.1. Introduction
Paget’s disease of bone, also known as osteitis deformans, is a
common disorder due to excessive and abnormal remodelling
of bone. The disease may affect virtually every bone in the
skeleton. Diagnosis is usually based upon clinical features,
imaging, and laboratory analyses.1
Both malignant and benign tumours may be found in asso-
ciation with Paget’s disease. There are a few case reports
describing the coexistence of Paget’s disease and bone meta-
static carcinoma.2–5
A nasopharyngeal carcinoma with asymptomatic Paget’s
disease may be difﬁcult to determine the stage. We report on
a case of a clinically localized undifferentiated nasopharyngeal
carcinoma coexisting with incidental bone Paget’s disease.
2. Case report
A51-year-old, postmenopausal womanwith a history of cardiac
arrhythmia had complained of a 6-month history of permanent
left nasal obstruction, epistaxis and left ear fullness associated
with an ipsilateral headache and a generally weak condition.
No bone pain or pathological fractures were reported by the pa-
tient. The nasal endoscopy showed a tumour of the left lateral
wall of the nasopharynx towards the posterior choanae. A 3-
cm-neck node was palpated in left region II. The neurological
examination was normal. Computed tomography (CT) and
MRI detected a tumour at the left posterolateral wall of the
nasopharynx reaching the ipsilateral choanae. The nasopharyn-
geal biopsy revealed an undifferentiated carcinoma (UCNT).
The tumour was classiﬁed as aT2 N1 according to the9 m-MCP bone scan show increa
one and the left sacroiliac joint.
avicle.UICC-AJCC system (2002).Diagnostic investigations including
chest X-ray and liver ultrasonography did not reveal anymetas-
tases. However, the bone scintigraphy showed widespread
homogenous increased uptake over the skull, sterno-clavicular
line, right clavicle, ﬁrst lumbar vertebra, right ankle and the ipsi-
lateral greater trochanter of the femur. An intense and diffuse
uptake was noted at the right iliac bone and at the left sacroiliac
joint (Fig. 1). The features were suggestive of a diffuse sclerotic
bone disorder. The differential diagnosis at the time included
Paget’s disease of the bone and bony metastases. X-rays subse-
quently obtained showed an increase in bone density and corti-
cal thickening especially in the right iliac bone (Fig. 2). Ased uptake over the sterno-clavicular line, the great trochanter of
(B) Anterior 99mTc-MCP bone scan show a high activity in the
Figure 3 Anteroposterior radiograph of the lumbar spine shows
trabecular thickening in the L5 vertebral body (arrow).
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encasing the ﬁrst lumbar vertebra margins which gives rise to
the ‘‘picture frame’’ (Fig. 3). These lesions were compatible with
Paget’s disease. Her serum calcium and phosphate levels were
normal but the serum alkaline phosphatase was elevated to
418 U/L (normal: 36–108 U/L). However, X-rays could not
eliminate the possibility of metastatic bone at the right ankle.
MRI of the right ankle, leg and knee did not reveal bone metas-
tasis. The tumour was ﬁnally classiﬁed aT2 N1M0. The patient
underwent concomitant radio-chemotherapy consisting of three
cycles of cisplatin and 5-ﬂuorouracil with cobalt external radio-
therapy (62 Gy over 6 weeks). The response as shown in a one-
year follow-up was good.
3. Discussion
Paget’s disease is characterized by rapid bone destruction and
simultaneous excessive bone repair, resulting in a distortion of
bone architecture.1,6 It affects 3–4% of those over the age
of 55 years. Paget’s disease expresses itself with polyostotic
(65–90%) or monostotic skeletal involvement.6,7 In the major-
ity of patients, it is asymptomatic and only detected as an inci-
dental ﬁnding on X-rays or radionuclide bone scan performed
for unrelated reasons or by the discovery of elevated serum
alkaline phosphatase.1,2
Paget’s disease may be associated with other diseases, such
as malignancies. In this situation it often poses a diagnostic
dilemma for the clinician since the ﬁrm diagnosis of Paget’s
disease in patients with cancer, and no deﬁnitive evidence of
metastasis, may save them from further unnecessary examina-
tion and aggressive therapy.2,6
An association between asymptomatic Paget’s disease and
cancer was described. The malignancies most commonly asso-
ciated with Paget’s disease are prostatic, breast and lung
tumours.2,3,8 We report the ﬁrst case to our knowledge of
the coexistence of nasopharyngeal carcinoma and Paget’s dis-
ease in the English literature.
UCNT have several unusual characteristics that make them
unique amongst human epithelial malignancies. This includes
their epidemiology, clinical features, pathology, treatment
and outcome. In Tunisia, the incidence of UCNT is moderate
as compared to other endemic areas (3–4/100,000).9,10Nevertheless it represents the most frequent oto-rhino-laryn-
gology (ORL) cancer in females and the second after larynx
carcinoma in males. UCNT shows a high frequency of distant
metastasis compared with other tumours of the head and neck.
Over distant metastasis has been detected in up 11% of UCNT
patients at initial staging by conventional studies, with the
skeleton, involved in 70–80% of patients with distant
metastasis.11
At its early stage, metastasis starts in the bone marrow, pre-
dominantly the highly vascularized red marrow. Before corti-
cal bone invasion becomes obvious, there are probably
plenty of active tumour cells occupying the bone marrow.
The bone matrix undergoes constant remodelling which
involves maintaining a dynamic balance between osteoclastic
and osteoblastic activities.
Generally, lesions with active tumour proliferation give
higher osteolytic activity, while lesions under resolution or
repair have higher osteoblastic activity and may appear
sclerotic.12
Nasopharyngeal carcinoma is a relatively common cause of
sclerotic metastatic bone lesions. Sham et al. showed that 20%
of patients developed bone metastases mainly involving the
axial skeleton during follow-up, with 21% of the bone lesions
being sclerotic.13
The spine and pelvis are the more frequently involved sites,
followed by the thorax and the appendix.13 Polyostic Paget’s
disease tends to have right-sided predominance and is more
often asymmetrical in distribution.6,7 It involves the cranium
(25–65%), vertebral column (30–75%), sacrum (30–60%), pel-
vis (30–75%), femur (25–35%) and tibia.1,3
The main biologic characteristic is the elevation of total
alkaline phosphatase (TAK). Biochemical markers of bone
resorption are also increased in the serum or urine, or both,
of most patients with Paget’s disease.1,14 However, TAK is a
widely used test in metastatic bone disease. Markers of bone
resorption and formation are also increased in bone metastasis
(even in the lytic or blastic form of the disease).15,16
Paget’s disease demonstrates a wide spectrum of radiologic
patterns and appearances related to the phase of disease seen
pathologically. Radiography is sufﬁcient for diagnosis in the
majority of cases and typically reveals pathognomonic changes
in the lytic phase of Paget’s disease, with sharply deﬁned areas
of osteolysis in the skull or beginning in subchondral bone of
the appendicular skeleton; in the mixed phase, with character-
istic trabecular and cortical thickening and bone enlargement;
and in the blastic phase with areas of sclerosis.
Bone enlargement as well as trabecular and cortical thick-
ening are also seen on CT and MR images, with the additional
frequent ﬁnding of maintained yellow marrow in noncompli-
cated Paget’s disease.7
However, X-rays may appear normal especially in the early
stages of the disease. In these situations, bone scintigraphy
may be helpful in establishing the diagnosis. In Paget’s disease
increased osteoblastic activity in bone is demonstrated by bone
scintigraphy. It classically demonstrates increased uptake in
the region of abnormal bone in all three phases of the disease.
It is a sensitive but not speciﬁc examination.6,7
The sensitivity and speciﬁcity of bone scintigraphy in bone
metastases of UCNT are, respectively, 66.7% and 86.8%. It
has a positive predictive value of 10% and a negative predic-
tive value of 99.2% with accuracy of 86.3%.17 Bone scintigra-
phy appears to be insensitive for detecting early bone or bone
128 B. Hammami et al.marrow metastasis.18,19 Therefore, differentiation between
malignant and benign lesions by bone scintigraphy is problem-
atic, even with experienced nuclear physicians.19
FDG PET has been proven to be more sensitive than bone
scintigraphy for detecting bone metastases in primary staging
of UCNT patients. It has a sensitivity of 70%, a speciﬁcity
of 99%, and an accuracy of 95%. FDG PET is superior to
bone scintigraphy for metastatic lesions in the spine, pelvic
bones and extremities. This is probably related to the larger
marrow space at these sites. For the thoracic cage, bone scin-
tigraphy appears more sensitive. The osteoblastic reaction in
the ribs seems also to be easily detected by bone scintigraphy.12
FDG PET can also differentiate benign from malignant tis-
sue in many tumours, in that increased glycolysis of malignant
tissue being reﬂected in enhanced accumulation of this tracer.
Cook et al. showed that the majority of patients with Paget’s
disease show no abnormal accumulation of FDG in bones.
Only few patients showed marked uptake of FDG at a level
that could be mistaken for malignant tissue. They concluded
that a positive scan would require further investigation but a
negative study would be reassuring that no malignancy was
present.20 In our case, we do not have an FDG PET in our
country that is why we could not use it for differentiating
between metastatic lesions and Paget’s disease of bone.
In conclusion, the coexistence of nasopharyngeal carci-
noma and Paget’s disease of bone poses a diagnostic dilemma
to the clinician since the ﬁrm diagnosis of Paget’s disease, and
the assurance that there is no metastasis may save the patient
from unnecessary examination and aggressive therapy. In this
case, the FDG PET may be helpful, especially when there is no
increased uptake.
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